Psoriasis treatment patterns with etanercept and adalimumab in a United States health plan population

By Chastek Benjamin  

Journal of Dermatological Treatment, Vol. 24, Iss. 1, 2013-02 ,pp. : 25-33

Informa Healthcare

Access to resources Recommend Favorite

Transient and Slight Thrombocytopaenia Induced by Etanercept During Treatment of Psoriatic Arthritis

By Stinco Giuseppe   Piccirillo Fabio   Patrone Pasquale  

Acta Dermato-Venereologica, Vol. 88, Iss. 3, 2008-05 ,pp. : 281-282

Medical Journals Limited

Access to resources Recommend Favorite

Onset of palmoplantar pustular psoriasis while on adalimumab for psoriatic arthritis: A ‘class effect’ of TNF-α antagonists or simply an anti-psoriatic treatment adverse reaction?

By Rallis Efstathios   Korfitis Chrysovalantis   Stavropoulou Evgenia   Papaconstantis Markos  

Journal of Dermatological Treatment, Vol. 21, Iss. 1, 2010-01 ,pp. : 3-5

Informa Healthcare

Access to resources Recommend Favorite

Rapid Growth of Merkel Cell Carcinoma During Etanercept Treatment of Psoriatic Arthritis: Cause or Coincidence?

By de Giorgi Vincenzo   Benemei Silvia   Grazzini Marta   Lotti Torello   Geppetti Pierangelo  

Acta Dermato-Venereologica, Vol. 91, Iss. 3, 2011-05 ,pp. : 354-355

Medical Journals Limited

Access to resources Recommend Favorite

Severe pyoderma gangrenosum unresponsive to etanercept and adalimumab

By Kleinpenning Marloes M.   Langewouters Annechien M. G.   Van De Kerkhof Peter C. M.   Greebe Rens J.  

Journal of Dermatological Treatment, Vol. 22, Iss. 5, 2011-10 ,pp. : 261-265

Informa Healthcare

Access to resources Recommend Favorite